Skip to main content
SpringerLink
Log in

The Liver in Systemic Critical Illness

  • Chapter
  • First Online:
Hepatic Critical Care

  • 1338 Accesses

Abstract

Liver dysfunction may manifest during systemic illness as a consequence of circulatory compromise — inadequate perfusion, passive congestion, intrahepatic redistribution of blood flow — or as a consequence of hepatocellular or fixed tissue macrophage (Kupffer cell) cytotoxicity. It is probable that hepatic dysfunction exacerbates the hemodynamic sequelae and multisystem dysfunction which results from infection. Certainly, underlying hepatocellular disease such as that caused by steatosis, viral hepatitis which results in changes to the cytoarchitecture will predispose to hepatocellular dysfunction in systemic illness.

Some discrete functions of the liver can be measured. However, several key aspects related to immune function are poorly characterized. Liver dysfunction is often inferred from extrahepatic organ dysfunction the severity of which can be quantified and used to characterize the severity of liver dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Pant C, Olyaee M, Gilroy R, Pandya PK, Olson JC, Oropeza-Vail M, Rai T, Deshpande A. Emergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011. Medicine. 2015;94(1):e308.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, Garcia-Tsao G, Kamath PS. Intensive care of the patient with cirrhosis. Hepatology. 2011;54(5):1864–72.

    Article  PubMed  Google Scholar 

  3. Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Austrian Epidemiologic Study on Intensive Care, ASDI Study Group. Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med. 2007;35(4):1099–104.

    Article  PubMed  Google Scholar 

  4. Maynard ND, Bihari DJ, Dalton RN, Beale R, Smithies MN, Mason RC. Liver function and splanchnic ischemia in critically ill patients. Chest. 1997;111(1):180–7.

    Article  CAS  PubMed  Google Scholar 

  5. Koch A, Horn A, Duckers H, Yagmur E, Sanson E, Bruensing J, Buendgens L, Voigt S, Trautwein C, Tacke F. Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU. Crit Care. 2011;15(6):R266.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ozawa K, Aoyama H, Yasuda K, et al. Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch Surg. 1983;118:1245–51.

    Article  CAS  PubMed  Google Scholar 

  7. Rolla G, Brussino L, Colagrande P, Dutto L, Polizzi S, Scappaticci E, Bergerone S, Morello M, Marzano A, Martinasso G, Salizzoni M, Bucca C. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology. 1997;26(4):842–7.

    Article  CAS  PubMed  Google Scholar 

  8. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, Jones GJ. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J. 1995;8(11):1883–5.

    Article  CAS  PubMed  Google Scholar 

  9. Fernandez Del Rio R, O’Hara ME, Holt A, Pemberton P, Shah T, Whitehouse T, Mayhew CA. Volatile biomarkers in breath associated with liver cirrhosis – comparisons of pre- and post-liver transplant breath samples. EBioMedicine. 2015;2(9):1243–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kortgen A, Paxian M, Werth M, Recknagel P, Rauchfuss F, Lupp A, Krenn CG, Muller D, Claus RA, Reinhart K, Settmacher U, Bauer M. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock. 2009;32(4):358–65.

    Article  PubMed  Google Scholar 

  11. Cieslak KP, Huisman F, Bais T, Bennink RJ, van Lienden KP, Verheij J, Besselink MG, Busch ORC, van Gulik TM. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization. Surgery. 2017;162(1):37–47.

    Article  PubMed  Google Scholar 

  12. Karvellas CJ, Pink F, McPhail M, Austin M, Auzinger G, Bernal W, Sizer E, Kutsogiannis DJ, Eltringham I, Wendon JA. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med. 2010;38(1):121–6.

    Article  PubMed  Google Scholar 

  13. Karvellas CJ, Bagshaw SM. Advances in management and prognostication in critically ill cirrhotic patients. Curr Opin Crit Care. 2014;20(2):210–7.

    Article  PubMed  Google Scholar 

  14. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastro. 2013;144:1426–37.

    Article  Google Scholar 

  15. Boone MD, Celi LA, Ho BG, Pencina M, Curry MP, Lior Y, Talmor D, Novack V. Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients. J Crit Care 2014; 29(5):881.e7–13.

    Google Scholar 

  16. Schlichtig R, Klions HA, Kramer DJ, Nemoto EM. Hepatic dysoxia commences during O2 supply dependence. J Appl Physiol. 1992;72(4):1499–505.

    Article  CAS  PubMed  Google Scholar 

  17. Weemhoff JL, Woolbright BL, Jenkins RE, McGill MR, Sharpe MR, Olson JC, Antoine DJ, Curry SC, Jaeschke H. Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis. Liver Int. 2017;37(3):377–84.

    Article  CAS  PubMed  Google Scholar 

  18. Fuhrmann V, Jäger B, Zubkova A, Drolz A. Hypoxic hepatitis—epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122:129–39.

    Article  PubMed  Google Scholar 

  19. Matuschak GM, Pinsky MR, Klein EC, Van Thiel DH, Rinaldo JE. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am Rev Respir Dis. 1990;141(5 Pt 1):1296–306.

    Article  CAS  PubMed  Google Scholar 

  20. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.

    Article  CAS  PubMed  Google Scholar 

  21. Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30:580–8.

    Article  CAS  PubMed  Google Scholar 

  22. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G, Bernard GR. For the recombinant human activated protein C worldwide evaluation in severe sepsis (PROWESS) study group: effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med. 2003;31:834–40.

    Article  CAS  PubMed  Google Scholar 

  23. Whitehead MW, Hainsworth I, Kingham JG. The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut. 2001;48(3):409–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology. 2007;45(1):230–41.

    Article  CAS  PubMed  Google Scholar 

  25. Bhogal HK, Sanyal AJ. The molecular pathogenesis of cholestasis in sepsis. Front Biosci. 2013;5:87–96.

    Article  Google Scholar 

  26. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. 2014;33(6):498–510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kobashi H, Toshimori J, Yamamoto K. Sepsis-associated liver injury: incidence, classification and the clinical significance. Hepatol Res. 2013;43(3):255–66.

    Article  PubMed  Google Scholar 

  29. Srivastava B, Gimson A. Hepatic changes in systemic infection. Best Pract Res Clin Gastroenterol. 2013;27(4):485–95.

    Article  CAS  PubMed  Google Scholar 

  30. Wang D, Yin Y, Yao Y. Advances in sepsis-associated liver dysfunction. Burns Trauma. 2014;2(3):97–105.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Howell MD, Davis AM. Management of sepsis and septic shock. JAMA. 2017;317(8):847–8.

    Article  PubMed  Google Scholar 

  32. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res. 2003;109(2):144–8.

    Article  CAS  PubMed  Google Scholar 

  33. Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151(6):1229–38.

    Article  PubMed  Google Scholar 

  34. May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013;19(17):2068–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Nesseler N, Launey Y, Aninat C, Morel F, Malledant Y, Seguin P. Clinical review: the liver in sepsis. Crit Care. 2012;16(5):235.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Moreno R, Sprung CL, Annane D, Chevret S, Briegel J, Keh D, Singer M, Weiss YG, Payen D, Cuthbertson BH, Vincent J. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the CORTICUS study. Intensive Care Med. 2011;37:1765–72.

    Article  CAS  PubMed  Google Scholar 

  37. Kubitz R, Wettstein M, Warskulat U, Häussinger D. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology. 1999;116:401–10.

    Article  CAS  PubMed  Google Scholar 

  38. Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology. 2002;36:395–402.

    Article  CAS  PubMed  Google Scholar 

  39. Tsai MH, Peng YS, Chen YC, Liu NJ, Ho YP, Fang JT, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology. 2006;43:673–81.

    Article  PubMed  Google Scholar 

  40. Marik PE. Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm! Intensive Care Med. 2016;42(9):1475–7.

    Article  PubMed  Google Scholar 

  41. Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J Clin Endocrinol Metab. 2009;94:2345–52.

    Article  CAS  PubMed  Google Scholar 

  42. Portella AO, Montero EF, deFigueiredo P. Effects of N-acetylcysteine in hepatic ischemia-reperfusion injury during hemorrhagic shock. Transplant Proc. 2004;39:846–8.

    Article  Google Scholar 

  43. Farrell SJ, Aldag E, Pedersen R, Sahajpal A, Clendenon J, Gunabushanam V, Kramer DJ. Evaluation of the effects of N-Acetylcysteine treatment in adult liver transplant recipients. J Pharm Soc Wis. 2016;19(6):49–52.

    Google Scholar 

  44. Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al. On behalf of the RELIEF study group. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153–62.

    Article  PubMed  Google Scholar 

  45. Dunn GD, Hayes P, Breen KJ, Schenker S. The liver in congestive heart failure: a review. Am J Med Sci. 1973;265(3):174–89.

    Article  CAS  PubMed  Google Scholar 

  46. Sherlock S. The liver in heart failure; relation of anatomical, functional, and circulatory changes. Br Heart J. 1951;13(3):273–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Lau GT, Tan HC, Krithrades L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol. 2002;90:1405–9.

    Article  PubMed  Google Scholar 

  48. Allen LA, Felker GM, Pocock S, et al. CHARM investigators. Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail. 2009;11(2):170–7.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Van Deursen VM, Damman K, Hillege HL, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail. 2010;16:84–90.

    Article  PubMed  Google Scholar 

  50. Henrion J, Schapira M, Luwaert R, et al. Hypoxic hepatitis. Medicine. 2003;82(6):392–406.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aurora Critical Care Service, Aurora Health Care, 2901 West Kinnickinnic River Parkway, Suite 315, Milwaukee, WI, USA

    Tessa W. Damm D.O. & David J. Kramer M.D.

  2. Medical College of Wisconsin, Milwaukee, WI, USA

    Gaurav Dagar M.B.B.S.

  3. School of Medicine and Public Health, University of Wisconsin, 2901 West Kinnickinnic River Parkway, Suite 315, Milwaukee, WI, USA

    David J. Kramer M.D.

Authors
  1. Tessa W. Damm D.O.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gaurav Dagar M.B.B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David J. Kramer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Kramer M.D. .

Editor information

Editors and Affiliations

  1. Medical Intensive Care Unit, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Rahul Nanchal

  2. Emory University, Atlanta, Georgia, USA

    Ram Subramanian

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Damm, T.W., Dagar, G., Kramer, D.J. (2018). The Liver in Systemic Critical Illness. In: Nanchal, R., Subramanian, R. (eds) Hepatic Critical Care . Springer, Cham. https://doi.org/10.1007/978-3-319-66432-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66432-3_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66431-6

  • Online ISBN: 978-3-319-66432-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation